HBI Spotlight

 

Vivalto Santé to hoover up hospitals after LBO

Vivalto Partners, a new investment fund founded by the CEO of France's third-largest hospital group Vivalto Santé, has bought a controlling stake in the hospital group. HBI hears that Vivalto Santé will focus on further consolidating western France while Vivalto Partners wants to acquire other healthcare businesses.

Second round bids in for Unilabs

Global lab and imaging group Unilabs is in the second round of its sales process, HBI hears, with four bidders made up of private equity and strategic buyers.

Biogroup acquires Analiza/Cerba Internacional

Biogroup, the fast consolidator of the French lab market, has moved into the Iberian peninsular for the first time by acquiring two assets: Analiza and Cerba Internacional. HBI hears the multiple looks very, very low. 

Dentistry: Rodericks Dental, KonfiDents sell

Two more dentistry platforms have been grabbed by two different private equity firms. NHS focused UK dental group Rodericks Dental has sold, HBI hears from multiple sources, and so has German-based KonfiDents. We name the buyers, the multiple, and consider why this development might shake up a stagnating market.

Will Babylon succeed?

Ali Parsa, the founder of Babylon Health, is now a paper billionaire with control of a business with an enterprise value of $3.6bn with an additional $575m in gross proceeds, following its merger with special acquisition vehicle Alkuri. The nearly 90% of the SPAC shareholders who chose to sell before the shares started trading may be kicking themselves - the shares peaked at $16 on October 26, though as of the time of writing are sitting at $10.82, up from the initial opening price of 10$ on October 22.

“Secret” Artemis sale talks, as Veonet process progresses

HBI understands that Montagu, owners of Artemis Augenkliniken which is Germany’s second-largest ophthalmology chain by revenue, is in bilateral talks to sell. HBI names the potential buyer, and also has a delve into the ongoing sale - and current finances - of Veonet Group.

Icade Sante book ‘not hugely oversubscribed’

REIT Icade had only covered the book of Icade Sante by 1.25x the €800m it was hoping to raise, HBI is told. Earlier this week it permanently postponed an IPO citing volatile markets. 

Babylon losing $0.4m a day as SPAC merger imminent

Babylon says it will complete its SPAC merger in mid-October, with the company reporting five-fold revenue growth in the first half. New American contracts have proved extremely lucrative for the UK-based telehealth company - but it expects to lose money for another two years. 

Voyage Care ‘about to sell’

HBI hears from multiple sources that the largest special adult care provider in the UK, Voyage Care, is about to be put up for sale. We look at how, why and when its longstanding private equity (PE) owners could make an exit.

Find Us